People

Kindeva Drug Delivery  has announced the appointment of Denis Johnson as Chief Operating Officer. Johnson was most recently Head of Global Manufacturing at Biogen and had previously served in executive roles at Catalent Pharma Solutions and Boston Scientific. The company noted that one of Johnson's focuses will be on Kindeva's efforts around transitioning MDIs to LGWP … [Read more...] about Kindeva Drug Delivery names Denis Johnson as Chief Operating Officer

Kindeva Drug Delivery  has named former West Pharmaceutical Services Senior Director, Business and Technical Operations, Jennifer Riter as VP of Analytical Services. Earlier this year, Kindeva announced the launch of its new analytical services business, which will offer medical device, container closure, and extractables and leachables testing. Riter worked in … [Read more...] about Kindeva appoints Jenifer Riter as VP of Analytical Services

Oragenics, which describes itself as "a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders" has announced the resignation of CEO Kimberly Murphy as part of "a mutually agreeable Separation Agreement." The company specified that Murphy's resignation "was not due to any disagreement with the Company … [Read more...] about Oragenics CEO Kimberly Murphy resigns

Adherium has announced that former Novartis executive Paul Mastoridis will succeed Rick Legleiter as CEO of the Hailie inhaler monitoring system maker. Legleiter recently announced his resignation from the company. Mastoridis was most recently Global Medical Head of Respiratory at Novartis and previously served as a brand director for respiratory at that company. … [Read more...] about Adherium announces the appointment of Paul Mastoridis as CEO

Iconovo has announced that OINDP expert Gary Pitcairn will join the company as Senior Scientific Advisor to support development projects, particularly reformulation of drugs for inhalation. Pitcairn, who was most recently Chief Scientific Officer at Nanologica, previously headed respiratory groups at AstraZeneca, Mylan, Pfizer, and Pharmaceutical Profiles. He is also … [Read more...] about Gary Pitcairn joins Iconovo as Senior Scientific Advisor

After recently raising $175 million for continued development of AP01 inhaled pirfenidone and AP02 inhaled nintedanib, Avalyn Pharma has announced four new executive hires. The new appointments include former Boehringer Ingelheim interstitial lung disease (ILD) expert Craig Conoscenti as Senior VP, clinical development; Jim Bishop as Senior VP, Business Operations; … [Read more...] about Avalyn Pharma announces appointment of four executives

Gossamer Bio, which is developing its seralutinib DPI for the treatment of pulmonary arterial hypertension (PAH), has announced the appointment of Rainer Zimmermann as VP of Medical Affairs.  Zimmermann was most recently Global Medical Leader, Pulmonary Hypertension, at Janssen. Prior to Johnson & Johnson, Zimmermann served as Global Medical Lead, PH Franchise, at … [Read more...] about Gossamer Bio names Rainer Zimmermann as VP of Medical Affairs

US-based Avalyn Pharma has announced the appointment of former Aerami Therapeutics Chief Development Officer Melissa Rhodes as Chief Operating Officer, a newly created position. Avalyn, which is developing AP01 inhaled pirfenidone and AP02 inhaled nintedanib for the treatment of pulmonary fibrosis, recently announced the appointment of Howard Lazarus as Chief Medical … [Read more...] about Melissa Rhodes joins Avalyn Pharma as Chief Operating Officer